News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
483,258 Results
Type
Article (8015)
Company Profile (139)
Press Release (475008)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (166760)
Career Advice (305)
Deals (25740)
Drug Delivery (7)
Drug Development (52875)
Employer Resources (14)
FDA (9761)
Job Trends (8575)
News (238244)
Policy (17922)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (481)
Accelerated approval (21)
ADA (18)
Adcomms (1)
Allergies (94)
Alliances (33155)
ALS (102)
Alzheimer's disease (966)
Antibody-drug conjugate (ADC) (255)
Approvals (10343)
Artificial intelligence (310)
ASCO (159)
Autoimmune disease (197)
Automation (28)
Bankruptcy (262)
Best Places to Work (6958)
BIO (36)
BIOSECURE Act (1)
Biosimilars (104)
Biotechnology (88)
Bladder cancer (132)
Brain cancer (28)
Breast cancer (501)
Cancer (3568)
Cardiovascular disease (213)
Career advice (245)
Career pathing (1)
CAR-T (169)
Celiac Disease (1)
Cell therapy (469)
Cervical cancer (34)
Clinical research (47747)
Collaboration (1209)
Commercialization (1)
Compensation (1393)
Complete response letters (33)
COVID-19 (750)
CRISPR (62)
C-suite (709)
Cystic fibrosis (84)
Data (5515)
Denatured (4)
Depression (101)
Dermatology (60)
Diabetes (336)
Diagnostics (4154)
Digital health (36)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (147)
Drug pricing (7)
Drug shortages (2)
Duchenne muscular dystrophy (158)
Earnings (73055)
Editorial (1)
Employer branding (2)
Employer resources (14)
Events (87447)
Executive appointments (682)
FDA (12294)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (23)
Funding (895)
Gene editing (123)
Generative AI (9)
Gene therapy (309)
GLP-1 (286)
Government (940)
Grass and pollen (2)
Guidances (280)
Healthcare (9307)
Hematology (94)
HIV (52)
Huntington's disease (22)
IgA nephropathy (60)
Immunology and inflammation (97)
Immuno-oncology (55)
Indications (151)
Infectious disease (936)
Inflammatory bowel disease (125)
Inflation Reduction Act (4)
Influenza (83)
Intellectual property (247)
Interviews (41)
IPO (12378)
IRA (2)
Job creations (1968)
Job search strategy (235)
JPM (1)
Kidney cancer (16)
Layoffs (59)
Legal (5195)
Liver cancer (43)
Longevity (15)
Lung cancer (492)
Lymphoma (242)
Machine learning (27)
Management (3)
Manufacturing (513)
Marketing (7)
MASH (116)
Medical device (8635)
Medtech (8758)
Mergers & acquisitions (14353)
Metabolic disorders (692)
mRNA (50)
Multiple sclerosis (102)
NASH (4)
Neurodegenerative disease (213)
Neuropsychiatric disorders (38)
Neuroscience (1787)
NextGen: Class of 2026 (3150)
Non-profit (841)
Obesity (219)
Opinion (10)
Ovarian cancer (156)
Pain (169)
Pancreatic cancer (191)
Parkinson's disease (196)
Partnered (11)
Patents (458)
Patient recruitment (479)
Peanut (31)
People (41122)
Pharmaceutical (30)
Pharmacy benefit managers (8)
Phase 1 (15433)
Phase 2 (21322)
Phase 3 (14356)
Pipeline (6678)
Policy (18)
Postmarket research (1570)
Preclinical (6526)
Press Release (34)
Prostate cancer (187)
Psychedelics (7)
Radiopharmaceuticals (187)
Rare diseases (558)
Real estate (3019)
Recruiting (6)
Regulatory (14693)
Reports (16)
Research institute (578)
Resumes & cover letters (45)
Rett syndrome (39)
RNA editing (5)
RSV (47)
Schizophrenia (99)
Series A (149)
Series B (118)
Service/supplier (4)
Sickle cell disease (62)
Spinal muscular atrophy (87)
Sponsored (5)
Startups (2018)
Stomach cancer (3)
Supply chain (49)
Vaccines (311)
Venture capital (17)
Weight loss (72)
Women's health (75)
Date
Today (41)
Last 7 days (255)
Last 30 days (1083)
Last 365 days (19072)
2026 (10800)
2025 (19251)
2024 (22985)
2023 (26539)
2022 (34593)
2021 (37176)
2020 (33479)
2019 (23256)
2018 (17468)
2017 (18765)
2016 (17917)
2015 (24263)
2014 (21683)
2013 (18138)
2012 (20221)
2011 (20440)
2010 (20332)
Location
Africa (227)
Alabama (71)
Alaska (2)
Arizona (293)
Arkansas (11)
Asia (17844)
Australia (2090)
California (11536)
Canada (3044)
China (505)
Colorado (465)
Connecticut (390)
Delaware (203)
Europe (24566)
Florida (1718)
Georgia (364)
Hawaii (2)
Idaho (46)
Illinois (680)
India (42)
Indiana (308)
Iowa (13)
Japan (387)
Kansas (98)
Kentucky (30)
Louisiana (24)
Maine (25)
Maryland (1155)
Massachusetts (7593)
Michigan (299)
Minnesota (540)
Mississippi (4)
Missouri (78)
Montana (20)
Nebraska (11)
Nevada (112)
New Hampshire (60)
New Jersey (2540)
New Mexico (12)
New York (2737)
North Carolina (1230)
North Dakota (4)
Northern California (5746)
Ohio (269)
Oklahoma (14)
Oregon (14)
Pennsylvania (2192)
Puerto Rico (20)
Rhode Island (30)
South America (406)
South Carolina (75)
South Dakota (1)
Southern California (4784)
Tennessee (114)
Texas (1860)
United States (37532)
Utah (345)
Vermont (1)
Virginia (146)
Washington D.C. (38)
Washington State (895)
West Virginia (1)
Wisconsin (73)
483,258 Results for "biolargo inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
BioLargo Revenue Continues Breaking Records as Water Technologies Ready for Commercialization
BioLargo, Inc. (OTCQB:BLGO), developer of sustainable technologies and a full-service environmental engineering company, filed with the SEC its Quarterly Report on Form 10-Q for the period ended September 30, 2020 ( www.biolargo.com/sec-filings ). BioLargos Third Quarter Accomplishments Record revenue - generated record revenues in the third quarter, rebounding from early pandemic shutdowns
November 16, 2020
·
6 min read
Biotech Bay
BioLargo Awarded Contract for Engineering Services at Major Chemical Manufacturing Facility
BioLargo, Inc, announced today that its subsidiary BioLargo Engineering, Science & Technologies (BLEST) has been awarded a contract to assist in the reconfiguration of the Regenerative Thermal Oxidizer (RTO) systems used at a large chemical manufacturing plant on the East Coast of the US, owned by a global chemical company,
October 21, 2020
·
3 min read
Biotech Beach
BioLargo (BLGO) to Present at LD Micro Invitational XI
BioLargo, Inc. (OTCQB:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced today that it will be giving an investor presentation at the upcoming LD Micro virtual event on Wednesday, June 9, 2021, at 5:00 PM ET.
June 4, 2021
·
4 min read
Biotech Beach
BioLargo to Present at H.C. Wainwright 23rd Annual Global Investment Conference on September 13, 2021
BioLargo, Inc. will present at the H.C. Wainwright 23rd Annual Global Investment Conference. The conference is being held virtually on September 13-15, 2021.
September 8, 2021
·
3 min read
Biotech Beach
BioLargo Inc. to Present at Benzinga Cleantech Small Cap Conference on April 22nd at 11:20am EST
BioLargo, Inc. (OTCQB:BLGO), developer of sustainable clean technologies and a full-service environmental engineering company will be presenting at the Benzinga Cleantech Small Cap Conference on Earth Day, April 22, 2021, at 11:20am EST.
April 14, 2021
·
4 min read
Biotech Beach
BioLargo Q2 2021 Earnings Results Webcast and Conference Call Wednesday, August 17, 2021 - 11:00 AM Eastern Time
BioLargo, Inc. will host an investor webcast and conference call on Wednesday August 17, 2021, at 8:00 am PST / 11:00 am EST, open to the public, to review the company’s financial results, discuss recent events, and conduct a question-and-answer session.
August 10, 2021
·
2 min read
Business
BioLargo (BLGO) Q1 2021 Earnings Webcast and Conference Call Wednesday, May 19, 2021 - 4:30 PM Eastern Time
BioLargo, Inc., a developer of sustainable clean- technologies and full-service environmental engineering company, will host an investor webcast and conference call on Wednesday May 19, 2021, at 1:30 pm PT / 4:30 pm ET, open to the public.
May 12, 2021
·
3 min read
Business
BioLargo 2020 Annual Report Highlights Expanding Commercial Traction for its Cleantech Technologies, Record Revenue Growth and Improved Balance Sheet
BioLargo, Inc., a developer of sustainable cleantech technologies and full-service environmental engineering company, filed its Annual Report on Form 10-K with the SEC for the year ended December 31, 2020.
March 31, 2021
·
8 min read
Press Releases
Encision Inc. Announces Start of Stock Trading
July 14, 2026
·
1 min read
BioLargo Subsidiary Clyra Medical’s Clyraguard Product Shows Complete Inactivation of SARS-CoV-2 Virus in Galveston National Lab Study
BioLargo, Inc. announced that Clyraguard, the product developed by its partially owned subsidiary Clyra Medical Technologies in response to the COVID-19 pandemic has been successfully shown to cause complete inactivation of the SARS-CoV-2 virus in laboratory testing.
May 21, 2020
·
4 min read
1 of 48,326
Next
